Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment.
暂无分享,去创建一个
G. Gessa | A. Imperato | M. Casu | L. Dazzi | M. S. Mascia | M. Obinu | G. Carta | M. Mascia
[1] G. Gessa,et al. Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? , 1994, European journal of pharmacology.
[2] G. Gessa,et al. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. , 1993, The Journal of pharmacology and experimental therapeutics.
[3] L. Hansen,et al. Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity , 1993, Journal of psychopharmacology.
[4] B. Bunney,et al. Depolarization inactivation of dopamine neurons: Terminal release characteristics , 1993, Synapse.
[5] G. Lahoste,et al. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density , 1992, Synapse.
[6] A. Imperato,et al. Repeated stressful experiences differently affect limbic dopamine release during and following stress , 1992, Brain Research.
[7] H. Groenewegen,et al. Regulation of the activity of striatal cholinergic neurons by dopamine , 1992, Neuroscience.
[8] H. Fibiger,et al. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. , 1991, The Journal of pharmacology and experimental therapeutics.
[9] H. Fibiger,et al. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. , 1990, European journal of pharmacology.
[10] T. Chase,et al. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. , 1987, Science.
[11] T. Chase,et al. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. , 1986, European journal of pharmacology.
[12] K. Neve,et al. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat , 1984, Neuroscience Letters.
[13] G. Di Chiara,et al. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] S. Snyder,et al. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.
[15] R. Roth,et al. Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. , 1973, The Journal of pharmacology and experimental therapeutics.
[16] R. Roth,et al. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.
[17] B. Westerink,et al. A microdialysis and automated on-line analysis approach to study central cholinergic transmission in vivo , 1991 .
[18] G. Di Chiara,et al. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.